Unknown

Dataset Information

0

The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding.

ABSTRACT: Cyclic nucleotide phosphodiesterases (PDEs) regulate all pathways that use cGMP or cAMP as a second messenger. Five of the 11 PDE families have regulatory segments containing GAF domains, 3 of which are known to bind cGMP. In PDE2 binding of cGMP to the GAF domain causes an activation of the catalytic activity by a mechanism that apparently is shared even in the adenylyl cyclase of Anabaena, an organism separated from mouse by 2 billion years of evolution. The 2.9-A crystal structure of the mouse PDE2A regulatory segment reported in this paper reveals that the GAF A domain functions as a dimerization locus. The GAF B domain shows a deeply buried cGMP displaying a new cGMP-binding motif and is the first atomic structure of a physiological cGMP receptor with bound cGMP. Moreover, this cGMP site is located well away from the region predicted by previous mutagenesis and structural genomic approaches.

SUBMITTER: Martinez SE 

PROVIDER: S-EPMC130621 | biostudies-literature | 2002 Oct

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

The two GAF domains in phosphodiesterase 2A have distinct roles in dimerization and in cGMP binding.

Martinez Sergio E SE   Wu Albert Y AY   Glavas Natalie A NA   Tang Xiao-Bo XB   Turley Stewart S   Hol Wim G J WG   Beavo Joseph A JA  

Proceedings of the National Academy of Sciences of the United States of America 20020923 20

Cyclic nucleotide phosphodiesterases (PDEs) regulate all pathways that use cGMP or cAMP as a second messenger. Five of the 11 PDE families have regulatory segments containing GAF domains, 3 of which are known to bind cGMP. In PDE2 binding of cGMP to the GAF domain causes an activation of the catalytic activity by a mechanism that apparently is shared even in the adenylyl cyclase of Anabaena, an organism separated from mouse by 2 billion years of evolution. The 2.9-A crystal structure of the mous  ...[more]

Similar Datasets

Unknown Solution structure of the cGMP binding GAF domain from phosphodiesterase 5: insights into nucleotide specificity, dimerization, and cGMP-dependent conformational change.
| S-EPMC2504876 | biostudies-literature
Unknown Structural Analysis of the Regulatory GAF Domains of cGMP Phosphodiesterase Elucidates the Allosteric Communication Pathway.
| S-EPMC7572642 | biostudies-literature
Unknown The structure of the GAF A domain from phosphodiesterase 6C reveals determinants of cGMP binding, a conserved binding surface, and a large cGMP-dependent conformational change.
| S-EPMC2533791 | biostudies-literature
Proteomics Structural analysis of the regulatory GAF domains of cGMP phosphodiesterase elucidates the allosteric communication pathway
2022-02-15 | PXD020817 | Pride
Unknown Conformation changes, N-terminal involvement, and cGMP signal relay in the phosphodiesterase-5 GAF domain.
| S-EPMC2992248 | biostudies-literature
Unknown Crystal structure of the tandem GAF domains from a cyanobacterial adenylyl cyclase: modes of ligand binding and dimerization.
| S-EPMC549502 | biostudies-literature
Unknown Distinct functional roles for the two SLX4 ubiquitin-binding UBZ domains mutated in Fanconi anemia.
| S-EPMC4075355 | biostudies-literature
Unknown Two Polo-like kinase 4 binding domains in Asterless perform distinct roles in regulating kinase stability.
| S-EPMC4332252 | biostudies-literature
Unknown Upregulation of Phosphodiesterase 2A Augments T Cell Activation by Changing cGMP/cAMP Cross-Talk.
| S-EPMC8523859 | biostudies-literature
Unknown PDE5 is converted to an activated state upon cGMP binding to the GAF A domain.
| S-EPMC140735 | biostudies-literature